<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T03:02:23Z</responseDate>
  <request identifier="oai:figshare.com:article/34039039" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34039039</identifier>
        <datestamp>2026-10-01T05:11:37Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Substrate Selectivity
of Viperin Probed Using Anticancer-Related
Pyrimidine Nucleotide Analogs</dc:title>
          <dc:creator>Minshik Jo (13163182)</dc:creator>
          <dc:creator>Victor Rivera-Santana (25152361)</dc:creator>
          <dc:creator>Hanyu Su (18202420)</dc:creator>
          <dc:creator>Dillon P. Langford (18266687)</dc:creator>
          <dc:creator>E. Neil G. Marsh (8378205)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>generally high specificity</dc:subject>
          <dc:subject>elicited reductive cleavage</dc:subject>
          <dc:subject>3 ′- fluoroctp</dc:subject>
          <dc:subject>3 ′- deoxy</dc:subject>
          <dc:subject>natural antiviral nucleotide</dc:subject>
          <dc:subject>various drugs mimic</dc:subject>
          <dc:subject>antiviral enzyme</dc:subject>
          <dc:subject>drugs may</dc:subject>
          <dc:subject>anticancer drugs</dc:subject>
          <dc:subject>triphosphate forms</dc:subject>
          <dc:subject>substrate selectivity</dc:subject>
          <dc:subject>rna replication</dc:subject>
          <dc:subject>pyrimidine nucleosides</dc:subject>
          <dc:subject>last compound</dc:subject>
          <dc:subject>gemcitabine triphosphate</dc:subject>
          <dc:subject>examined whether</dc:subject>
          <dc:subject>either dna</dc:subject>
          <dc:subject>dehydrated products</dc:subject>
          <dc:subject>dehydrated product</dc:subject>
          <dc:subject>ddhctp ),</dc:subject>
          <dc:subject>autoimmune diseases</dc:subject>
          <dc:description>Many antiviral and anticancer drugs are based on the
structure
of pyrimidine nucleosides. Once phosphorylated, they function by interfering
with either DNA or RNA replication or transcription. The antiviral
enzyme, viperin, catalyzes the dehydration of CTP to produce 3′-deoxy-3′,4′-didehydroCTP
(ddhCTP), which functions as a natural antiviral nucleotide. Various
drugs mimic the structure of CTP, and furthermore, viperin is upregulated
in some cancers and autoimmune diseases. Therefore, we examined whether
such drugs may be substrates for viperin. A panel of eight commercially
available nucleosides, including several clinically used drugs, were
enzymatically converted to their triphosphate forms and investigated
as substrates for viperin. Five of the nucleotides were not substrates,
indicating that viperin has generally high specificity for CTP. Two
nucleotides, 3′-deoxy-3′-fluoroCTP and cytarabine triphosphate
elicited reductive cleavage of SAM and were converted to their dehydrated
products by viperin. The last compound, gemcitabine triphosphate,
elicited reductive cleavage of SAM, but no dehydrated product was
observed, implying that it activates SAM cleavage without undergoing
hydrogen atom abstraction. The implications of these results are discussed.</dc:description>
          <dc:date>2026-10-01T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.biochem.6c00226.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Substrate_Selectivity_of_Viperin_Probed_Using_Anticancer-Related_Pyrimidine_Nucleotide_Analogs/34039039</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
